Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CAO Sells $93,901.70 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,962 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $93,901.70. Following the completion of the sale, the chief accounting officer directly owned 251,676 shares of the company’s stock, valued at approximately $1,975,656.60. This trade represents a 4.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Deborah Stewart also recently made the following trade(s):

• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $95,128.44.

Aveanna Healthcare Trading Down 1.1%

AVAH stock traded down $0.09 during midday trading on Friday, hitting $8.08. The company had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock’s 50 day moving average price is $8.92 and its 200 day moving average price is $7.49.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The company had revenue of $450.53 million for the quarter. As a group, equities research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Truist Financial raised their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their price objective for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. BMO Capital Markets assumed coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They set an “outperform” rating and a $11.00 target price on the stock. William Blair began coverage on Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating for the company. Finally, Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Aveanna Healthcare has an average rating of “Hold” and an average price target of $10.69.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Summit Partners L P purchased a new stake in Aveanna Healthcare in the second quarter worth $50,477,000. Assenagon Asset Management S.A. purchased a new position in Aveanna Healthcare during the third quarter valued at $7,356,000. Strs Ohio bought a new stake in shares of Aveanna Healthcare during the 1st quarter valued at $218,000. Diversified Trust Co purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter worth about $57,000. Finally, Squarepoint Ops LLC grew its position in shares of Aveanna Healthcare by 207.0% in the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after buying an additional 323,656 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.